11 Okt 2016

How the Right Governance Structure can maximize your Partnership Value

Since the origins of Clinical Trials, the industry has witnessed an immense growth of partnerships and preferred service provider relationships between many CROs and their Pharma-clients.

In spite of these impressive numbers pharmaceutical companies and their CRO partners fail to reach the benefits expected by such partnerships. Development timelines have been increasing an average of 20 percent in respect to 5-10 years ago and similarly costs have reached more than 2 Billion USD per each new drug developed in a medium complexity situation. Also, it has been estimated that more than 80percent of partnerships fail to deliver more than 90percent of their expected value (e.g. savings, efficiencies, higher quality and shorter cycle times).

In this interesting article on CLINICALTRIALSARENA five main factors are explained to maximize a business partnership in Clinical Trials outsourcing…. [READ MORE]

(Foto: North Charleston - 2012 FIRST Robotics Competition Palmetto Regional/Flickr – CC BY-SA 2.0)